drug
ELVN-001
Phase 1updated 3mo agoby $ELVN Enliven Therapeutics, Inc.
Phase 1community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying ELVN-001
News(2)
- J&J looks to widen Imaavy’s use; $300M backs rare disease drug launchNew data suggest Imaavy could be an effective treatment for autoimmune anemia. Elsewhere, Enliven detailed data for a Merck leukemia rival and MBX hyperparathyroidism drug hit its goal.biopharma_dive · 2mo ago
- STAT+: Enliven Therapeutics’ leukemia drug shows promise in new studyA targeted drug from Enliven Therapeutics induced molecular responses in nearly half of patients with advanced leukemia, new data show.stat · 2mo ago
Data sources
last refreshed 11m ago
Found something off?
comments(0)
5-min edit window · permanent after that